Talquetamab vs real-world physicians choice of therapy (RWPC): comparative efficacy in patients (pts) with triple-class exposed (TCE) relapsed/ refractory multiple myeloma (RRMM)
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2023）
关键词
refractory multiple myeloma,multiple myeloma,comparative efficacy,rrmm,real-world,triple-class
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要